• Nenhum resultado encontrado

Respiratory infections in children up to two years of age on prophylaxis with palivizumab

N/A
N/A
Protected

Academic year: 2017

Share "Respiratory infections in children up to two years of age on prophylaxis with palivizumab"

Copied!
7
0
0

Texto

Loading

Referências

Documentos relacionados

Acute respiratory infections (ARI) caused by respiratory syncytial virus (RSV) were studied in 482 children from Salvador, BA, Brazil, over a period of 12 months.. The epidemic

Molecular epidemiology of human adenovirus isolated from children hospitalized with acute respiratory infection in São Paulo, Brazil.. Lower respiratory infections by

Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children.. Detection

In the follow-up of children with gestational ages between 24 and 28 weeks 24 there was a difference in terms of hospitalization rates due to respiratory diseases and in the number

The beginning of a new era: systematic testing for pathogens causing acute respiratory tract infections (ARI) in children.. Jornal de Pediatria

Objective: To describe hospitalization rates, burden of disease, and associated risk factors of acute respiratory infections (ARI), particularly those caused by respiratory

Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses iden- tified recently in infants with acute respiratory

This study aims to describe palivizumab use in high risk- infants, and to estimate the frequency of RSV hospitalization among infants and young children treated with palivizumab